ROTOP – DMSA (ROTOP Pharmaka GmbH)


Welcome to the PulseAid listing for the ROTOP – DMSA drug offered from ROTOP Pharmaka GmbH. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: ROTOP Pharmaka GmbH
NON-PROPRIETARY NAME: Kit for the Preparation of Technetium Tc99m Succimer Injection
SUBSTANCE NAME: 2,3-DIMERCAPTOSUCCINIC ACID
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
START MARKETING DATE: 2017-08-08
END MARKETING DATE: 0000-00-00


ROTOP – DMSA HUMAN PRESCRIPTION DRUG Details:

Item DescriptionROTOP – DMSA from ROTOP Pharmaka GmbH
LABELER NAME: ROTOP Pharmaka GmbH
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mg/1)
START MARKETING DATE: 2017-08-08
END MARKETING DATE: 0000-00-00
PRODUCT ID: 71647-001_1af92f46-ef15-4b08-a75b-7206f752d1e4
PRODUCT NDC: 71647-001
APPLICATION NUMBER:

Other 2,3-DIMERCAPTOSUCCINIC ACID Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AnazaoHealth CorporationDimercaptosuccinic Acid
ROTOP Pharmaka GmbHROTOP – DMSA